sijia ma

Dr. sijia ma

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SMsijia ma
sijia ma
BYBin Yang
Bin Yang
MZMingming Zhao
Mingming Zhao
PLPeng Li
Peng Li
JFJiao Fan
Jiao Fan
YZYu Zhang
Yu Zhang

5 June 2023 in Phytomedicine
Verified
Journal Article
Open access
SMsijia ma
sijia ma
MZMingming Zhao
Mingming Zhao
MCMeiying Chang
Meiying Chang
XSXiujie Shi
Xiujie Shi
YSYue Shi
Yue Shi
YZYu Zhang
Yu Zhang
Immunoglobulin A nephropathy (IgAN), is the main cause of end-stage renal disease, that causes serious physical and psychological burden to patients worldwide. Some traditional treatment measures, such as blocking the renin-angiotensin-aldosterone system, controlling blood pressure, and following a low-protein diet, may not achieve satisfactory results. Therefore, more effective and safe therapies for IgAN are urgently needed. The aim of this review is to summarize the clinical efficacy of Chinese herbal medicines (CHMs) and their active ingredients in the treatment and management of IgAN based on the results of clinical trials, systematic reviews, and meta-analyses, to fully understand the advantages and perspectives of CHMs in the treatment of IgAN. For this review, the following electronic databases were consulted: PubMed, ResearchGate, Science Direct, Web of Science, Chinese National Knowledge Infrastructure and Wanfang Data, "IgA nephropathy," "traditional Chinese medicine," "Chinese herbal medicine," "herb," "mechanism," "Meta-analysis," "systematic review," "RCT" and their combinations were the keywords to search the relevant literature. Data were collected from 1990 to 2022. This review found that the active ingredients of CHMs commonly act on multiple signaling pathways in the clinical treatment of IgAN, mainly with antioxidant, anti-inflammatory and anti-fibrosis effects, and regulation of autophagy. Compared with the single-target therapy of modern medicine, CHMs can regulate the corresponding pathways from the aspects of anti-inflammation, anti-oxidation, anti-fibrosis and autophagy to play a multi-target treatment of IgAN through syndrome differentiation and treatment, which has good clinical efficacy and can be used as the first choice or alternative therapy for IgAN treatment. This review provides evidence and research direction for a comprehensive clinical understanding of the protective effect of Chinese herbal medicine on IgAN.

1 December 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MZMingming Zhao
Mingming Zhao
YYYundong Yin
Yundong Yin
BYBin Yang
Bin Yang
MCMeiying Chang
Meiying Chang
SMsijia ma
sijia ma
YZYu Zhang
Yu Zhang

22 February 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MZMingming Zhao
Mingming Zhao
ZZZiyan Zhang
Ziyan Zhang
ZPZhiyu Pan
Zhiyu Pan
SMsijia ma
sijia ma
MCMeiying Chang
Meiying Chang
YZYu Zhang
Yu Zhang
Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in order to explore better subtypes of CCB for the treatment of CKD. This meta-analysis of 12 RCTs with 967 CKD patients who were treated with RAS inhibitors demonstrated that, when compared with L-type CCB, N-/T-type CCB was superior in reducing urine albumin/protein excretion (SMD, −0.41; 95% CI, −0.64 to −0.18; p < 0.001) and aldosterone, without influencing serum creatinine (WMD, −3.64; 95% CI, −11.63 to 4.35; p = 0.37), glomerular filtration rate (SMD, 0.06; 95% CI, −0.13 to 0.25; p = 0.53), and adverse effects (RR, 0.95; 95% CI, 0.35 to 2.58; p = 0.93). In addition, N-/T-type CCB did not decrease the systolic blood pressure (BP) (WMD, 0.17; 95% CI, −1.05 to 1.39; p = 0.79) or diastolic BP (WMD, 0.64; 95% CI, −0.55 to 1.83; p = 0.29) when compared with L-type CCB. In CKD patients treated with RAS inhibitors, N-/T-type CCB is more effective than L-type CCB in reducing urine albumin/protein excretion without increased serum creatinine, decreased glomerular filtration rate, and increased adverse effects. The additional benefit is independent of BP and may be associated with decreased aldosterone (PROSPERO, CRD42020197560).

9 July 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMsijia ma
sijia ma
LQLinlin Qian
Linlin Qian
YJYuhua Jiang
Yuhua Jiang
MWMeng Wang
Meng Wang
SXShijie Xu
Shijie Xu
CWChao Wang
Chao Wang
Background: The aim of this study is to explore the association between the systemic immune-inflammatory index (SII) and stress urinary incontinence (SUI). Methods: We used information obtained from the National Health and Nutrition Examination Survey (NHANES) that was conducted between 2007 and 2016. The weighted multivariate logistic regression model was used in order to evaluate the relationship that exists between the SII index and the SUI measurement. In addition, a technique from the field of smooth curve fitting was used to investigate the linear connection that exists between these variables. In order to determine whether or not the SII index and SUI relationship remained stable across a variety of demographic strata, subgroup analyses were carried out. Results: The research had a grand total of 20,849 individuals. After full adjustment for confounders, each 1-unit increase in log₁₀(SII) was associated with a 29.7% increase in the odds of SUI (OR=1.297, 95%CI 1.028–1.636, P = 0.032). Categorizing the SII index into quartiles revealed that even in the highest SII quartile, there remained a significant positive association with SUI when compared to the lowest quartile (OR =1.177, 95%CI 1.013–1.368, P = 0.038). Furthermore, an augmented correlation between alcohol consumption and SUI was detected among drinkers compared to non-drinkers ( P < 0.05). Conclusions: Higher systemic inflammatory burden reflected by SII is statistically significantly associated with increased odds of SUI in the U.S. adult population, though the effect size is small; this association is particularly prominent in alcohol drinkers.